·¬ΗΡΙηΗψapp

Meeting Coverage

AAN

American Academy of Neurology

Novel Drug Made of Gold Nanocrystals Appears Safe in Multiple Sclerosis

Small study suggested benefits for MS patients with chronic optic neuropathy

AAN over a photo of Colorado Convention Center in Denver, CO

Latest AAN Meeting Coverage

Novel Treatment Appears to Show Benefit in ALS

Ciprofloxacin and celecoxib formulation aims to target several ALS mechanisms

April 18, 2024
Ocrelizumab Trial Fills Research Gap for Black, Hispanic MS Patients

Half of patients had no evidence of disease activity at 48 weeks

April 18, 2024
Alzheimer's Agitation Relapse Delayed With Dextromethorphan-Bupropion

Data suggest clinical response with few adverse effects for patients

April 17, 2024
Why an ALS Drug Was Pulled From the Market

Topline data show where sodium phenylbutyrate and taurursodiol fell short

April 17, 2024
No New Safety Signals Seen With Migraine Prevention Drug

At 48 weeks, atogepant showed consistent safety profile and efficacy

April 16, 2024
Possible Pulmonary Benefit With Viltolarsen for Duchenne Muscular Dystrophy

Exon-skipping therapy was well-tolerated, phase II data showed

April 16, 2024
Algorithm Predicts Disability From Point-of-Care EEGs

Hospitalized patients with seizure burden of at least 50% had poor outcomes

April 16, 2024
Brain Iron Accumulates With Post-Traumatic Headache

Findings may point to novel biomarker

April 5, 2024
Breastfeeding While Taking MS Monoclonal Antibody Drugs Appears Safe

No negative effects on early infant development or health seen

March 11, 2024
Dementia More Common in People With Essential Tremor

Prevalence greater than normal aging, but not as high as Parkinson's disease

March 6, 2024
Memory, Cognitive Symptoms Linked to Sleep Apnea

Findings highlight importance of early screening for apnea, researcher says

March 4, 2024
Parkinson's Risk Tied to More Pesticides

Simazine, atrazine, lindane in the Rocky Mountain and Great Plains region emerge in new analysis

February 27, 2024
SMA in Adults: Interim Data Back Nusinersen Efficacy

New trial focuses on drug's performance in spinal muscular atrophy beyond childhood

April 27, 2023
Confirmed: Mast Cell Drug Curbs ALS Mortality

Trial's long-term follow-up fills gap left from primary analysis

April 26, 2023

Videos

AAN Video Pearls
May 2023